A carregar...
Advance in Targeted Immunotherapy for Graft-Versus-Host Disease
Graft-versus-host disease (GVHD) is a serious and deadly complication of patients, who undergo hematopoietic stem cell transplantation (HSCT). Despite prophylactic treatment with immunosuppressive agents, 20–80% of recipients develop acute GVHD after HSCT. And the incidence rates of chronic GVHD ran...
Na minha lista:
| Publicado no: | Front Immunol |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Frontiers Media S.A.
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5964137/ https://ncbi.nlm.nih.gov/pubmed/29868032 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2018.01087 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|